Evelo Biosciences, Inc.
USD0.00
+0.00 (+0.00%)
CEO
Craig R. Jalbert
IPO Date
2018-05-08
Sector
Healthcare
Industry
Biotechnology
Exchange
OTC
Country
US
Open
$0.00
Prev. Close
$0.00
Day Low
$0.00
Day High
$0.00
52W Low
$0.00
52W High
$0.00
Market Cap
$0.00B
Volume
0.00M
| -2.6 |
| 31 Dec 2020 | FY | 0.0% | 0.0% | -307.3% | -103.3% | 1.31 | 3.58 | -5.1 |
| 31 Dec 2019 | FY | 0.0% | 0.0% | -142.3% | -94.2% | 0.33 | 7.99 | -1.5 |
| 31 Dec 2018 | FY | 0.0% | 0.0% | -39.3% | -33.7% | 0.09 | 16.02 | -5.3 |
| 31 Dec 2017 | FY | 0.0% | 0.0% | -95.4% | -64.1% | 0.34 | 10.10 | -2.1 |
| 31 Dec 2016 | FY | 0.0% | 0.0% | -241.3% | -71.8% | 1.80 | 6.99 | -3.4 |
| -0.2 |
| 31 Mar 2023 | Q1 | 0.0% | 0.0% | 92.5% | -60.4% | -1.85 | 0.53 | -0.2 |
| 31 Dec 2022 | Q4 | 0.0% | 0.0% | 471.6% | -36.5% | -10.24 | 4.16 | -1.9 |
| 30 Sept 2022 | Q3 | 0.0% | 0.0% | -327.4% | -35.4% | 5.88 | 2.69 | -1.8 |
| 30 Jun 2022 | Q2 | 0.0% | 0.0% | -85.7% | -27.3% | 1.55 | 4.52 | -1.3 |
| 31 Mar 2022 | Q1 | 0.0% | 0.0% | 177.7% | -50.8% | -3.32 | 2.67 | -1.5 |
| 31 Dec 2021 | Q4 | 0.0% | 0.0% | -330.6% | -32.6% | 6.50 | 4.09 | -2.8 |
| 30 Sept 2021 | Q3 | 0.0% | 0.0% | -102.0% | -29.0% | 1.72 | 4.72 | -2.8 |
| 30 Jun 2021 | Q2 | 0.0% | 0.0% | -50.9% | -21.8% | 0.92 | 6.38 | -5.8 |